Fig. 3.
Patient-reported outcomes at baseline in EC-MPS converted and MMF continued group. (A) GSRS subscale scores (B) GIQLI subscale scores.
*denotes P values <0.001. Note the significantly impaired GSRS and GIQLI all subscale scores in EC-MPS converted group.
EC-MPS, enteric-coated mycophenolate sodium; MMF, mycophenolate mofetil; GSRS, Gastrointestinal Symptom Rating Scale; GIQLI, Gastrointestinal Quality of Life Index.